I have been discussing the nature of the trials for the vaccine and the different phases. This article discusses what each phase involves. I had thought that there were just three phases but it turns out that there are five, at least when it comes to cancer treatments, with just the middle three getting the most attention. I am not sure if that is the case for every new treatment.
Phase 0 trials are the first clinical trials done among people. They aim to learn how a drug is processed in the body and how it affects the body. In these trials, a very small dose of a drug is given to about 10 to 15 people.
Phase I trials aim to find the best dose of a new drug with the fewest side effects. The drug will be tested in a small group of 15 to 30 patients. Doctors start by giving very low doses of the drug to a few patients. Higher doses are given to other patients until side effects become too severe or the desired effect is seen. The drug may help patients, but Phase I trials are to test a drug’s safety. If a drug is found to be safe enough, it can be tested in a phase II clinical trial.
Phase II trials further assess safety as well as if a drug works. The drug is often tested among patients with a specific type of cancer. Phase II trials are done in larger groups of patients compared to Phase I trials. Often, new combinations of drugs are tested. Patients are closely watched to see if the drug works. However, the new drug is rarely compared to the current (standard-of-care) drug that is used. If a drug is found to work, it can be tested in a phase III clinical trial.
Phase III trials compare a new drug to the standard-of-care drug. These trials assess the side effects of each drug and which drug works better. Phase III trials enroll 100 or more patients.
Often, these trials are randomized. This means that patients are put into a treatment group, called trial arms, by chance. Randomization is needed to make sure that the people in all trial arms are alike. This lets scientists know that the results of the clinical trial are due to the treatment and not differences between the groups. A computer program is often used to randomly assign people to the trial arms.
There can be more than two treatment groups in phase III trials. The control group gets the standard-of-care treatment. The other groups get a new treatment. Neither you nor your doctor can choose your group. You will also not know which group you’re in until the trial is over.
Every patient in a phase III study is watched closely. The study will be stopped early if the side effects of the new drug are too severe or if one group has much better results. Phase III clinical trials are often needed before the FDA will approve the use of a new drug for the general public.
Phase IV trials test new drugs approved by the FDA. The drug is tested in several hundreds or thousands of patients. This allows for better research on short-lived and long-lasting side effects and safety. For instance, some rare side effects may only be found in large groups of people. Doctors can also learn more about how well the drug works and if it’s helpful when used with other treatments.
So the safety of a drug and whether it has the desired effect should have been already established in the Phase II trials. The Phase III trial is to see how the new treatment compares with the existing standard of care and also monitor to see if any new side effects occur. In normal trials, the control group is given the best existing treatment. In the case of covid-19, there is no existing vaccine. So the aim of the Phase III covid-19 vaccine trial is not to establish safety and whether the drug works (both of which presumably have been established in the Phase II trials) but to measure the effectiveness on some kind of absolute scale using the placebo group for comparison. At least, that is how I read this document.
Of course, any of these trials are relevant to effectiveness and safety since some rare events may only show up in the large scale, long-term phase III and phase IV trials.
Meanwhile, we seem to be well into the post-Thanksgiving, post-holiday season spike in confirmed cases and deaths.
States reported 2 million tests, 223k cases, 128,947 people currently hospitalized with COVID-19, and 3,915 deaths. pic.twitter.com/w792tRxiaT
— The COVID Tracking Project (@COVID19Tracking) January 15, 2021